1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane has been researched along with myricitrin in 1 studies
| Studies (1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane) | Trials (1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane) | Recent Studies (post-2010) (1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane) | Studies (myricitrin) | Trials (myricitrin) | Recent Studies (post-2010) (myricitrin) |
|---|---|---|---|---|---|
| 36 | 1 | 9 | 119 | 0 | 90 |
| Protein | Taxonomy | 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane (IC50) | myricitrin (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 4.944 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 4.944 | |
| MPI protein | Homo sapiens (human) | 30.965 | |
| Aurora kinase B | Homo sapiens (human) | 3.89 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moriwaki, M; Yokomizo, A | 1 |
1 other study(ies) available for 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane and myricitrin
| Article | Year |
|---|---|
Myricitrin degraded by simulated digestion inhibits oxidation of human low-density lipoprotein.
Topics: alpha-Tocopherol; Amidines; Antioxidants; Apolipoprotein B-100; Apolipoproteins B; Chelating Agents; Cholesterol; Chromatography, High Pressure Liquid; Copper; Digestion; Edetic Acid; Flavonoids; Gastrointestinal Tract; Humans; Hydrogen-Ion Concentration; Lipoproteins, LDL; Molecular Structure; Oxidation-Reduction; Phenethylamines; Spectrum Analysis | 2005 |